VF
CARM

Virtu Financial’s Carisma Therapeutics CARM Stock Holding History

Virtu Financial’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,854
Closed -$6K – 1715
2025
Q3 		$6K Buy
+22,854
New +$7.55K ﹤0.01% 1365
2025
Q1 		– Sell
-17,327
Closed -$7K – 1416
2024
Q4 		$7K Buy
+17,327
New +$14.3K ﹤0.01% 1411
2023
Q2 		– Sell
-15,335
Closed -$48K – 1550
2023
Q1 		$48K Buy
+15,335
New +$146K 0.01% 1104
2022
Q4 		– Sell
-3,640
Closed -$31K – 1661
2022
Q3 		$31K Buy
+3,640
New +$49.6K ﹤0.01% 1307
2022
Q1 		– Sell
-9,560
Closed -$156K – 1539
2021
Q4 		$156K Buy
+9,560
New +$192K 0.02% 935
2021
Q3 		– Sell
-3,679
Closed -$340K – 1545
2021
Q2 		$340K Sell
3,679
-11,674
-76% -$744K 0.03% 653
2021
Q1 		$798K Buy
15,353
+1,853
+14% +$87.4K 0.06% 319
2020
Q4 		$365K Buy
13,500
+8,015
+146% +$203K 0.04% 550
2020
Q3 		$154K Buy
5,485
+2,332
+74% +$46.6K 0.03% 643
2020
Q2 		$45K Buy
+3,153
New +$42.5K 0.01% 1017
2019
Q4 		$204K Buy
9,799
+4,080
+71% +$93.8K 0.02% 927
2019
Q3 		$134K Sell
5,719
-8,295
-59% -$194K 0.01% 1038
2019
Q2 		$420K Buy
14,014
+9,740
+228% +$292K 0.02% 612
2019
Q1 		$88K Buy
+4,274
New +$73.8K 0.01% 1146
2018
Q4 		– Sell
-898
Closed -$39K – 1584
2018
Q3 		$39K Sell
898
-1,019
-53% -$39.7K ﹤0.01% 1332
2018
Q2 		$75K Sell
1,917
-373
-16% -$16.4K ﹤0.01% 1702
2018
Q1 		$48K Sell
2,290
-19,062
-89% -$366K ﹤0.01% 1724
2017
Q4 		$346K Buy
21,352
+19,425
+1,008% +$361K 0.02% 1140
2017
Q3 		$61K Buy
+1,927
New +$53.9K ﹤0.01% 2198

Other funds holding CARM

MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
OP
ORG Partners Roanoke, Indiana $568M AUM 24.16% 1-Year Est. Return

Virtu Financial's CARM Position: Q4 2025 in Review

Virtu Financial sold out of Carisma Therapeutics (CARM) in Q4 2025, closing a stake of 22,854 shares — an estimated $6K sold.

Virtu Financial first reported a position in CARM in Q3 2017 and held it in 19 quarters. The position peaked at $798K in Q1 2021. 7 funds tracked by Wall St. Rank hold CARM as of Q4 2025.

  • Virtu Financial reported no remaining Carisma Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 22,854 Carisma Therapeutics shares in Q4 2025, an estimated $6K.
  • Virtu Financial first reported a position in Carisma Therapeutics in Q3 2017 and held it in 19 quarters.
  • Virtu Financial's Carisma Therapeutics position peaked at $798K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.